$heff's $tation of $tocks & $olid DD

[$heff]

Alert...bought shares of AEZS at $1.27 in the Established Portfolio. Market is down 127 and this looks to me like a bottom for AEZS This price is close to my first purchase at $1.19. Nothing material has happened with the company like a failed trial or non-approval of a drug. All these biotechs raise money but it is when they do it that is important. Institutional Buying is happening at $1.35 as the company is selling 11 million shares. I think this was their (AEZS) best opportunity to raise money knowing the positive news is upcoming from future meetings. These are not flippers but institutions that know that strong things are in store for the company. Many forward-looking events & catalysts for this company! AEZS is raising money from a position of strength & not weakness IMO. Still significantly undervalued at this level compared to it partner for perifosine (KERX)IMO. $heff